Syndax Pharmaceuticals OverviewSyndax Pharmaceuticals Operating Income
Operating Income for SNDX.
Quarterly Operating Income
$-34202000.00
↓ 59.17% YoY
As of Mar 31, 2026
Annual Operating Income (TTM)
$-223529000.00
↓ 35% YoY
Trailing 12 months ending Mar 31, 2026